Dr. Novotny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vapa Health Care Systems, 3801 Miranda Ave
Palo Alto, CA 94304Phone+1 650-493-5000
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1986 - 1990
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1983 - 1986
University of California San Diego School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1991 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 8233 citationsBEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCERHerbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John D. Hainsworth
The New England Journal of Medicine. 2004-06-03 - 706 citationsBevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.Napoleone Ferrara, Kenneth J. Hillan, William Novotny
Biochemical and Biophysical Research Communications. 2005-07-29 - 1918 citationsDiscovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNapoleone Ferrara, Kenneth J. Hillan, Hans-Peter Gerber, William Novotny
Nature Reviews. Drug Discovery. 2004-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
